246 related articles for article (PubMed ID: 21289989)
21. Curcuminoid-loaded poly(methyl methacrylate) nanoparticles for cancer therapy.
Sahu A; Solanki P; Mitra S
Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):101-105. PubMed ID: 29593406
[TBL] [Abstract][Full Text] [Related]
22. Intestinal permeation enhancement of docetaxel encapsulated into methyl-β-cyclodextrin/poly(isobutylcyanoacrylate) nanoparticles coated with thiolated chitosan.
Mazzaferro S; Bouchemal K; Skanji R; Gueutin C; Chacun H; Ponchel G
J Control Release; 2012 Sep; 162(3):568-74. PubMed ID: 22902592
[TBL] [Abstract][Full Text] [Related]
23. TPGS-chitosan cross-linked targeted nanoparticles for effective brain cancer therapy.
Agrawal P; Singh RP; Sonali ; Kumari L; Sharma G; Koch B; Rajesh CV; Mehata AK; Singh S; Pandey BL; Muthu MS
Mater Sci Eng C Mater Biol Appl; 2017 May; 74():167-176. PubMed ID: 28254282
[TBL] [Abstract][Full Text] [Related]
24. PLA/PLGA nanoparticles for sustained release of docetaxel.
Musumeci T; Ventura CA; Giannone I; Ruozi B; Montenegro L; Pignatello R; Puglisi G
Int J Pharm; 2006 Nov; 325(1-2):172-9. PubMed ID: 16887303
[TBL] [Abstract][Full Text] [Related]
25. Gastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxel.
Shi LL; Lu J; Cao Y; Liu JY; Zhang XX; Zhang H; Cui JH; Cao QR
Drug Dev Ind Pharm; 2017 May; 43(5):839-846. PubMed ID: 27487431
[TBL] [Abstract][Full Text] [Related]
26. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
27. Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation.
Allam AN; Hamdallah SI; Abdallah OY
Int J Nanomedicine; 2017; 12():4733-4745. PubMed ID: 28740381
[TBL] [Abstract][Full Text] [Related]
28. Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa.
Dünnhaupt S; Barthelmes J; Hombach J; Sakloetsakun D; Arkhipova V; Bernkop-Schnürch A
Int J Pharm; 2011 Apr; 408(1-2):191-9. PubMed ID: 21295123
[TBL] [Abstract][Full Text] [Related]
29. Preparation and optimization of N-trimethyl-O-carboxymethyl chitosan nanoparticles for delivery of low-molecular-weight heparin.
Mahjub R; Heidari Shayesteh T; Radmehr M; Vafaei SY; Amini M; Dinarvand R; Dorkoosh FA
Pharm Dev Technol; 2016; 21(1):14-25. PubMed ID: 25255172
[TBL] [Abstract][Full Text] [Related]
30. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
[TBL] [Abstract][Full Text] [Related]
31. Tuning of shell and core characteristics of chitosan-decorated acrylic nanoparticles.
Bravo-Osuna I; Ponchel G; Vauthier C
Eur J Pharm Sci; 2007 Feb; 30(2):143-54. PubMed ID: 17157487
[TBL] [Abstract][Full Text] [Related]
32. Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies.
Bayat A; Dorkoosh FA; Dehpour AR; Moezi L; Larijani B; Junginger HE; Rafiee-Tehrani M
Int J Pharm; 2008 May; 356(1-2):259-66. PubMed ID: 18289808
[TBL] [Abstract][Full Text] [Related]
33. The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery.
Millotti G; Perera G; Vigl C; Pickl K; Sinner FM; Bernkop-Schnürch A
Drug Deliv; 2011 Apr; 18(3):190-7. PubMed ID: 21039318
[TBL] [Abstract][Full Text] [Related]
34. Preparation and characterization of self-assembled nanoparticles based on low-molecular-weight heparin and stearylamine conjugates for controlled delivery of docetaxel.
Kim DH; Termsarasab U; Cho HJ; Yoon IS; Lee JY; Moon HT; Kim DD
Int J Nanomedicine; 2014; 9():5711-27. PubMed ID: 25525355
[TBL] [Abstract][Full Text] [Related]
35. The counterbalanced effect of size and surface properties of chitosan-coated poly(isobutylcyanoacrylate) nanoparticles on mucoadhesion due to pluronic F68 addition.
Petit B; Bouchemal K; Vauthier C; Djabourov M; Ponchel G
Pharm Res; 2012 Apr; 29(4):943-52. PubMed ID: 22146804
[TBL] [Abstract][Full Text] [Related]
36. Thiolated chitosan nanoparticles as an oral delivery system for Amikacin: in vitro and ex vivo evaluations.
Atyabi F; Talaie F; Dinarvand R
J Nanosci Nanotechnol; 2009 Aug; 9(8):4593-603. PubMed ID: 19928123
[TBL] [Abstract][Full Text] [Related]
37. Peptide conjugated polymeric nanoparticles as a carrier for targeted delivery of docetaxel.
Kulhari H; Pooja D; Shrivastava S; V G M N; Sistla R
Colloids Surf B Biointerfaces; 2014 May; 117():166-73. PubMed ID: 24632389
[TBL] [Abstract][Full Text] [Related]
38. Development of conjugate-by-conjugate structured nanoparticles for oral delivery of docetaxel.
Ha-Lien Tran P; Wang T; Yang C; Tran TTD; Duan W
Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110346. PubMed ID: 31761193
[TBL] [Abstract][Full Text] [Related]
39. Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles.
Bravo-Osuna I; Vauthier C; Farabollini A; Palmieri GF; Ponchel G
Biomaterials; 2007 Apr; 28(13):2233-43. PubMed ID: 17261330
[TBL] [Abstract][Full Text] [Related]
40. Modified-chitosan nanoparticles: Novel drug delivery systems improve oral bioavailability of doxorubicin.
Khdair A; Hamad I; Alkhatib H; Bustanji Y; Mohammad M; Tayem R; Aiedeh K
Eur J Pharm Sci; 2016 Oct; 93():38-44. PubMed ID: 27473308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
